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Abstract Biotin-dependent human acetyl-CoA carboxylases
(ACCs) are integral in homeostatic lipid metabolism. By
securing posttranslational biotinylation, ACCs perform coor-
dinated catalytic functions allosterically regulated by
phosphorylation/dephosphorylation and citrate. The produc-
tion of authentic recombinant ACCs is heeded to provide a
reliable tool for molecular studies and drug discovery. Here,
we examined whether the human ACC2 (hACC2), an isoform
of ACC produced using the silkworm BmNPV bacmid sys-
tem, is equipped with proper posttranslational modifications
to carry out catalytic functions as the silkworm harbors an
inherent posttranslational modification machinery. Purified
hACC2 possessed genuine biotinylation capacity probed by
biotin-specific streptavidin and biotin antibodies. In addition,
phosphorylated hACC2 displayed limited catalytic activity
whereas dephosphorylated hACC2 revealed an enhanced en-
zymatic activity. Moreover, hACC2 polymerization, analyzed
by native page gel analysis and atomic force microscopy
imaging, was allosterically regulated by citrate and the
phosphorylation/dephosphorylation modulated citrate-
induced hACC2 polymerization process. Thus, the silkworm
BmNPV bacmid system provides a reliable eukaryotic protein
production platform for structural and functional analysis and
therapeutic drug discovery applications implementing suitable
posttranslational biotinylation and phosphorylation.
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Introduction
Acetyl-CoA carboxylases (ACCs) are biotin-dependent en-
zymes catalyzing the production of malonyl-CoA from
acetyl-CoA, a critical metabolic intermediate in lipid metabo-
lism (Brownsey et al. 2006; Kim 1997; Saggerson 2008; Tong
2013; Wakil and Abu-Elheiga 2009). Two different isoforms
of ACC, ACC1 and ACC2, partake in lipid metabolism in
humans and mammals (Abu-Elheiga et al. 1995, 1997; Ha
et al. 1996). ACC1, encoded byACACA, predominantly exists
in the cytosol of lipogenic organs such as adipose tissue and
liver where malonyl-CoA functions as a substrate for long
chain fatty acids synthesis. In contrast, ACACB-encoded
ACC2 is associated with the outer membrane of mitochondria
in oxidative tissues such as the heart, liver, and skeletal muscle
where malonyl-CoA is utilized as a negative regulator of fatty
acid oxidation. Due to the bifunctional roles in catabolic and
anabolic metabolism, ACC functions as a bioenergetics
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controller to promote stem cell function and tissue regenera-
tion to regulate lipid homeostasis (Folmes et al. 2013;
Fullerton et al. 2013; Knobloch et al. 2013; Park et al.
2013). Moreover, ACC2 knockout demonstrates anti-obesity
effects and prevention of cardiac remodeling (Abu-Elheiga
et al. 2001, 2003; Kolwicz et al. 2012). Therefore, ACC
activity regulation has been recognized as an attractive thera-
peutic target for dysregulated lipid metabolism such as obesi-
ty, diabetes, cancer, and cardiovascular disease (Tong and
Harwood 2006).
Eukaryotic ACCs, unlike prokaryotic ACCs composed of
three separate functional proteins, comprises three distinctive
functional domains, including a biotin carboxylase (BC) do-
main, a biotin carboxyl carrier protein domain (BCCP), and a
carboxyltransferase (CT) domain, to carry out multiple func-
tions. Integral in catalysis is biotin, a prosthetic group attached
to lysine residue within the BCCP domain (Bianchi et al.
1990; Cronan and Waldrop 2002; Tanabe et al. 1975; Tong
2013). The BC domain catalyzes the Mg-ATP-dependent
carboxylation of biotin to form carboxybiotin using bicarbon-
ate as the CO2 donor (reaction 1). Then, carboxybiotin is
transferred to the CT domain mediating transfer of the car-
boxyl group from carboxybiotin to acetyl-CoA to form
malonyl-CoA (reaction 2). Besides these core catalytic reac-
tions, ACC activities are allosterically regulated by multiple
factors including phosphorylation/dephosphorylation and cit-
rate (Beaty and Lane 1983a; Brownsey et al. 2006; Ha et al.
1994; Meredith and Lane 1978; Munday et al. 1988;
Wojtaszewski et al. 2003). Thus, ACC with posttranslational
biotinylation and properly regulated by allosteric modulators
is essential in evaluating the full functionality of multistep
reactions to unfold its functional mechanisms and systematic
inhibitor discovery efforts.
ATP−Mg2
þ þ HCO3− þ ACC−biotin↔ACC−biotin−CO2−




The baculovirus expression system has been considered as
the most efficient eukaryotic heterologous protein expression
system as the host insect cells can implement foolproof post-
translational modifications similar to higher eukaryotes (Kost
et al. 2005; Possee 1997). Two types of baculovirus expression
sys t ems , i . e . , Autographa ca l i f o rn ia mul t ip l e
nucleopolyhedrovirus (AcMNPV) and Bombyx mori
nucleopolyhedrovirus (BmNPV) systems, have been widely
used (Kost et al. 2005; Maeda 1989). We developed a BmNPV
bacmid, an Escherichia coli and B. mori hybrid shuttle vector, to
expedite the heterologous protein production platform without
construction and amplification of viruses in B. mori culture cells
as recombinant BmNPV DNA can be directly injected into
silkworm pupae or larvae (Hiyoshi et al. 2007; Motohashi
et al. 2005; Park et al. 2008a). Using the BmNPV bacmid
system, intracellular, extracellular, and membrane proteins have
been successfully generated with proper folding and posttransla-
tional modifications (Kato et al. 2010, 2012; Otsuki et al. 2013).
Here, we examined whether the recombinant human
ACC2, produced using the silkworm BmNPV bacmid-based
approach, secures proper posttranslational modifications to
fulfill the essential catalysis and allosteric modulation. We
report that ACC2, demonstrating consistent catalytic activities
with proper posttranslational biotinylation and phosphoryla-
tion, is regulated by allosteric modulation. Thus, silkworm-
based BmNPV system provides a reliable large-scale protein
production platform for structural and function studies as well
as drug discovery applications implementing essential post-
translational modifications.
Materials and methods
Construction of recombinant hACC2 BmNPV bacmid
The human ACC2 (2,548 amino acids) is associated with the
mitochondriamembrane through N-terminal 148 hydrophobic
amino acids classified as mitochondrial attachment and target
sequences (Tong 2013). To increase the solubility of recom-
binant human ACC2 (hACC2), these hydrophobic residues
were excluded using polymerase chain reaction (PCR) with
the following set of primers, 5′-GCCGTCGACATGTCCA
AAGAAGACAAGAAGCAG-3′ (forward), 5′-GCTCTAGA
TTACTTGTCATCGTCATCCTTGTAGTCGGTGGAGGC
CGGGCTGTCCATG-3′ (reverse), and designated as
Δ148aa-hACC2. The PCR cycle was performed following
30 cycles of denaturation at 94 °C for 30s, annealing at 55 °C
for 30s, and extension at 72 °C for 7 min, followed by a final
extension at 72 °C for 10 min. The complementary DNA of
human ACC2 from Mammalian Gene Collection (Thermo
Scientific, Pittsburgh, PA, USA) was used as a template. The
resultant PCR product was digested with SalI and XbaI
followed by purification with a GFX™ PCR DNA and Gel
Band Purification Kit (GE Healthcare, Amersham, UK). The
purified DNA fragment was ligated into pFastbac 1 vector,
which was transformed into E. coli competent DH5α cells
(Invitrogen, Carlsbad, CA, USA) and cultured on a solid LB
medium containing 100 μg/mL of ampicillin at 37 °C for 18 h
to generate recombinant plasmid. The plasmid containing
human Δ148aa-hACC2 gene was isolated and identified by
DNA sequencing. Finally, E. coli BmDH10bac-CP–-Chi–
competent cells containing the cysteine proteinase- and
chitinase-deficient BmNPV bacmid (Park et al. 2008a) were
transformed with the pFastbac1-Δ148aa-hACC2 and cultured
on a solid LB medium containing 50 μg/mL of kanamycin,
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7 μg/mL of gentamycin, 10 μg/mL of tetracycline, 40 μg/mL
of isopropyl β-D-1-thiogalactopyranoside (IPTG), and
100 μg/mL of 5-bromo-4-chloro-3-indolyl-4-galactoside (X-
Gal) (Takara Bio Inc., Otsu Shiga, Japan) at 37 °C for 18 h.
The bacmid containing BmNPV-Δ148aa-hACC2 was isolat-
ed from white positive colonies.
Expression and purification of recombinant hACC2
in silkworm
Silkworm pupae were used for the expression of recombinant
Δ148aa-hACC2 as a bioreactor. To produce recombinant
protein in pupae, 10 μg of BmNPV-Δ148aa-hACC2 bacmid
DNA was directly injected with DMRIE-C reagent
(Invitrogen) into the dorsal of pupae. The injected pupae were
reared at 27 °C for 6–7 days, and stored at –80 °C until further
analysis. Protein purification was carried out at 4 °C to min-
imize aggregation and protease activity. Five pupae were
homogenized in 10 mL of lysis buffer (50 mM Tris-HCl,
150 mM NaCl, pH 7.4, and 0.1 % TritonX-100) containing
an EDTA-free protease inhibitor tablet (Roche, Mannheim,
Germany) using a homogenizer (GLH-115, Yamato, Tokyo,
Japan). Cell debris was removed by pelleting through centri-
fugation at 12,000×g for 30 min. The supernatant was filtered
using a 0.45-μm syringe filter and loaded onto a 500-μL of
Anti-FLAG M2 antibody Affinity Gel (Sigma-Aldrich, St.
Louis, MO, USA) pre-equilibrated with equilibration buffer
(50 mM Tris-HCl, 150 mM NaCl, pH 7.4 and 0.02 %
TritonX-100). The column was washed with 2.5 mL of equil-
ibration buffer and eluted with elution buffer (100 μg/mL
FLAG peptide in 50 mM Tris-HCl and 150 mM NaCl,
pH 7.4). The eluted Δ148aa-hACC2 was collected and con-
centrated using a 100 K Amicon Ultra centrifugal filter
(Millipore, Billerica, MA, USA).
Confirmation of biotinylation and phosphorylation
by Western blotting
The posttranslational biotinylation and phosphorylation of
purified Δ148aa-hACC2 were measured by Western blotting
analysis. Prior to electrophoresis, purified sample was boiled
for 5 min at 95 °C with protein denaturing buffer (Nacalai
Tesque, Kyoto, Japan). Samples were electrophoresed in a
5 % SDS-PAGE gel with the Mini-protean system (Bio-Rad,
Hercules, CA, USA) at 150 V for 45–60 min in Tris-glycine
buffer (25 mM Tris, 250 mM glycine, pH 8.3, and 0.1 %
SDS). The separated proteins on a SDS-PAGE gel were
transferred to PVDF membranes (GE Healthcare) by
electroblotting on a wet blotter (Bio-Rad) at 15 V for 1 h. To
detect the purifiedΔ148aa-hACC2 and their biotinylation and
phosphorylation, several specific antibodies were used. A
mouse anti-FLAG antibody (Wako Pure Chem. Ind. Ltd.,
Osaka, Japan) was used to detect purified Δ148aa-hACC2
as a primary antibody. A monoclonal anti-phosphoserine an-
tibody (Sigma-Aldrich) was used for phosphorylation detec-
tion as a primary antibody. An anti-mouse IgG-HRP (GE
Healthcare) was used for above both cases as a secondary
antibody. A goat anti-biotin antibody (Abcam, Cambridge,
MA, USA) and streptavidin HRP conjugate (Thermo
Scientific, Rockford, IL, USA) were used for biotinylation
detection as a primary antibody. A rabbit anti-goat IgG-HRP
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and an
anti-mouse IgG-HRP were used as a secondary antibody.
Dephosphorylation of Δ148aa-hACC2
Dephosphorylation was carried out using Lambda protein
phosphatase (Lambda PP; New England Biolabs, Ipswich,
MA, USA). The purifiedΔ148aa-hACC2 was incubated with
0.5 μL of Lambda PP, 1X NEBuffer for protein
metallophosphatases (PMP) and 1 mM MnCl2 at 30 °C for
0, 1, 3, 6 h. Sterilized water instead of Lambda PP was used as
negative control. Dephosphorylation was confirmed by
Western blot using a monoclonal anti-phosphoserine antibody
(Sigma-Aldrich) produced in mouse and an anti-mouse IgG-
HRP (GE Healthcare). The activity of dephosphorylated
Δ148aa-hACC2 was determined using ACC assay.
Acetyl-CoA carboxylase assay
To measure ACC activity, 4 μL of purified Δ148aa-hACC2
was incubated with 36 μL of reaction buffer (50 mM of
HEPES, pH 7.4, 5 mM of NaHCO3, 10 mM of MgCl2,
10 mM of sodium citrate, 0.5 % of DMSO, 4 mM of ATP,
and 0.4 mM of acetyl-CoA) at 37 °C. The reaction was
terminated by addition of 4 μL of 100 % trichloroacetic acid.
The produced phosphate during the reaction was determined
using a SensoLyte® MG Phosphate Assay Kit (AnaSpec,
Fremont, CA, USA) by measuring the absorbance at
655 nm. Protein concentration was determined using BCA
protein assay kit (Thermo Scientific).
Citrate-induced polymerization of Δ148aa-hACC2
In order to confirm the allosteric regulation of purified
Δ148aa-hACC2 from silkworm, citrate-induced polymeriza-
tion was evaluated. The purified Δ148aa-hACC2 was incu-
bated with 50 mM of HEPES (pH 7.4), 1 mM of dithiothreitol
(DTT), and different concentration of citrate at 37 °C for
30 min. The polymerization was evaluated by Native-PAGE
and Western blotting. Purified proteins were prepared in a
non-denaturing sample buffer (Native sample buffer, Bio-
Rad). Samples were electrophoresed in a 5 % Native-PAGE
(without SDS) with the Mini-protean system (Bio-Rad) at
150 V for 45–60 min in Tris-glycine buffer (25 mM Tris and
250 mM glycine, pH 8.3). Next, Western blotting protocol
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was used as described above. The antibodies for detecting
polymerizedΔ148aa-hACC2 were same as used for detecting
purifiedΔ148aa-hACC2. The activity ofΔ148aa-hACC2 by
citrate concentration-dependent polymerization was deter-
mined by ACC assay.
Atomic force microscopy
Nanoscale AFM imaging was employed to investigate the
dynamic forms polymers due to allosteric regulation of
hACC2 by citrate. The Δ148aa-hACC2 was incubated with
or without 15 mM citrate for 20 min at 37 °C. The resultant
mixtures were placed on the freshly cleaved mica surface and
incubated for several hours in a moisture chamber. After
washing with water and drying under nitrogen, the samples
were subjected to tapping mode AFM imaging on the
Nanoscope IV PicoForce Multimode AFM, equipped with
an E-scanner and a rectangular-shaped silicon cantilever
(Bruker, Madison, WI, USA) with a 42-N/m spring constant
and a resonant frequency of ~300 kHz at ambient environment
(Park et al. 2008b; Park and Terzic 2010). Images (512×
512 pixels/image) were collected from each sample with
maximum image size of 5×5 μm and analyzed using the
Nanoscope Version 6.13 software (Bruker).
Results
Expression and purification of recombinant Δ148aa-hACC2
Human ACC2 is a large polypeptide comprised of a mito-
chondrial attachment domain, a mitochondrial target sequence
domain, a biotin carboxylase domain, a biotin carboxyl carrier
protein domain, and a carboxyltransferase domain (Fig. 1a)
(Bianchi et al. 1990; Tanabe et al. 1975; Tong 2013). Biotin is
covalently attached to lysine within BCCP domain through
posttranslational modification, and several serine residues are
phosphorylated by protein kinases (Beaty and Lane 1983a;
Brownsey et al. 2006; Ha et al. 1994; Meredith and Lane
1978). We deleted the N-terminal 148 hydrophobic amino
acids to enhance the solubility of heterologous protein, which
retains core functional modules (Fig. 1b). In particular, to
prevent protease activity and liquefaction of heterologous
proteins in silkworm-based expression system, E. coli
BmDH10bac-CP–-Chi– competent cells were employed.
Recombinant Δ148aa-hACC2 with a C-terminal FLAG
tag was purified using an anti-FLAG M2 affinity gel column.
Eluted with FLAG peptides, the enriched protein migrated to
~260 kDa, a predicted molecular weight, on SDS-PAGE
based on comparison with molecular weight markers
(Fig. 2a). Western blot analysis using a FLAG-specific anti-
body confirmed the expression of hACC2 (Fig. 2b). In addi-
tion, the yield of final purified Δ148aa-hACC2 was 495 μg/
pupa. This pupae-based recombinant protein expression pro-
vided a high yield of purified Δ148aa-hACC2 compared to
expression in silkworm larvae (150 μg/larva) (Park et al.
2013). The purified hACC2 displayed significant homogene-
ity on SDS-PAGE and Western blot analysis, thereby further
functional analysis was carried out using this enriched
Δ148aa-hACC2.
Biotinylation of Δ148aa-hACC2
The posttranslational modification with biotin in ACC2 is
essential to implement catalytic function. The biotin binding
residue in human ACC2 has not been clearly identified, yet
structural studies using nuclear magnetic resonance suggests
that biotin is attached to lysine 929 within a BCCP domain
(Lee et al. 2008). The biotinylation of Δ148aa-hACC2 from
the silkworm was analyzed by Western blotting using an anti-
biotin antibody. To further validate biotinylation of the
Δ148aa-hACC2, streptavidin HRP conjugate was employed
to detect the biotin group as streptavidin is known to interact

















A: Native human ACC2
B: Recombinant 148aa-human ACC2
Fig. 1 A schematic presentation of human ACC2 domains. a Native
hACC2. ACC2, human acetyl-CoA carboxylase 2; ATP, ATP-grasp do-
main; BC, biotin carboxylase domain; BCCP, biotin carboxyl carrier
protein domain; BS, biotinylation site; CT, carboxyltransferase domain;
M, membrane attachment domain;MT, mitochondria targeting sequence.
(b) Recombinant Δ148aa-hACC2. N-terminal 148 amino acids were
deleted for increasing the solubility. FLAG was tagged at its C-terminus
for affinity purification
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biotin band was detected more intensely than the streptavidin
bound band (Fig. 3), biotin-specific detection using two dif-
ferent methods confirmed hACC2 biotinylation. Collectively,
without additional supplement of biotin to generate biotinyl-
ated ACC observed in Trichoplusia ni cells (Kim et al. 2007),
silkworm enables to produce biotinylated heterologous
proteins.
Phosphorylation and dephosphorylation of Δ148aa-hACC2
Adenosine monophosphate-activated protein kinase
(AMPK)-mediated phosphorylation is other layer of post-
translational modification to allosterically regulate ACC cata-
lytic function. Phosphorylation inactivates ACC catalytic ac-
tivity whereas dephosphorylation activates the enzymatic
function. Notably, phosphorylation of Ser222 in hACC2
(Ser212 in mouse ACC2) has been recognized as a vital
process for homeostatic lipid metabolism (Fullerton et al.
2013; Wakil and Abu-Elheiga 2009). Consistent with these
findings, the crystal structure of biotin carboxylase domain of
hACC2 has revealed that the phosphorylation of Ser222 dis-
rupts the polymerization of ACC2, a widely recognizedmech-
anism in modulating catalytic function (Cho et al. 2010; Lee
et al. 2008).
We evaluated posttranslational phosphorylation of recom-
binantΔ148aa-hACC2, and then whether the phosphorylated
protein could be effectively dephosphorylated accompanying
the changes of catalytic function. Western blotting analysis
using a monoclonal anti-phosphoserine antibody demonstrat-
ed the phosphorylation ofΔ148aa-hACC2 purified from silk-
worm pupae (Fig. 4a). The addition of Lambda protein phos-
phatase, a Mn2+-dependent dephosphorylation enzyme, grad-
ually decreased the phosphorylation compared with control
(Fig. 4a), yet dephosphorylation was not completely achieved
inΔ148aa-hACC2 up to 6 h incubation. This finding suggests
that some of phosphorylation sites in full-length hACC2 could
be readily inaccessible by Lambda protein phosphatase unlike
isolated functional domains such as a biotin carboxylase do-
main (Kwon et al. 2013).
The effect of dephosphorylation was assessed by measur-
ing the catalytic function of Δ148aa-hACC2 (Fig. 4b).
Δ148aa-hACC2 was treated with and without Lambda pro-
tein phosphatase for 2 h, and then catalytic activity was
measured as a function of incubation time. Purified Δ148aa-
hACC2 with indigenous posttranslational phosphorylation
provided a specific activity of 0.786±0.229 nmol Pi/mg/min
(n=6), whereas phosphatase treated Δ148aa-hACC2 protein
yielded a specific activity of 1.336±0.441 nmol Pi/mg/min
(n=6), about 2-fold increase. These measurements are con-
sistent with the findings observed in knock-in mice samples
where Ser212 (mouse sequence) is replaced with alanine
to ablate the critical serine phosphorylation (Fullerton
et al. 2013).
Allosteric activation of Δ148aa-hACC2 by citrate
Citrate-induced polymerization has been extensively
employed to understand the regulatory mechanism of ACC,
although the concentrations of citrate required for allosteric
activation are much higher than that present at physiological














Fig. 2 The expression of recombinant Δ148aa-hACC2 was confirmed
by analysis of SDS-PAGE (a) and Western blot (b). MW, molecular
weight markers; Lane 1, protein extracts after infection; Lane 2, flow
through during FLAG-tag purification; Lane 3, purified and concentrated
Δ148aa-hACC2. An anti-FLAG M2 antibody and an anti-mouse IgG-
HRP were used to detect purified Δ148aa-hACC2
220
kDa 
MW Lane1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 
(A) Anti-Biotin (B) Streptavidin 
Fig. 3 The purified Δ148aa-hACC2 possesses posttranslational bio-
tinylation confirmed by Western blot analysis using an anti-biotin anti-
body (A) and streptavidin HRP conjugate (B). MW, molecular weight
markers; Lanes 1 and 4, protein extracts after infection; Lanes 2 and 5,
flow through during FLAG-tag purification; Lanes 3 and 6, purified and
concentratedΔ148aa-hACC2. An anti-biotin antibody and a streptavidin
HRP conjugate were used as primary antibodies. A rabbit anti-goat IgG-
HRP and an anti-mouse IgG-HRP were used as secondary antibodies
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et al. 2010). Upon incubation with citrate, ACC polymerizes
into filamentous structures containing 10–20 protomer units
with increased functional activity (Kim et al. 2007; Locke
et al. 2008). Regardless of biological significance of citrate
in ACC regulation, the citrate binding sites have not been
identified.
The citrate-induced allosteric activation of Δ148aa-
hACC2 was investigated by measuring the modulation of
structural and functional properties. Incubation of Δ148aa-
hACC2 with citrate generated the formation of high mo-
lecular weight polymers detected on Native-PAGE, which
was increased with rising citrate concentrations (Fig. 5a).
This polymerization results indicate that Δ148aa-hACC2
derived from pupae consists of dimers and tetramers based
on comparison with molecular weight markers, and in-
creased citrate concentrations led to tetramer production
by decreasing dimers (Fig. 5a). Consistent with dose-
dependent polymerization, the catalytic activity of
Δ148aa-hACC2 was also enhanced with increasing citrate
concentrations (Fig. 5b). Incubation of Δ148aa-hACC2
with 5, 10, and 20 mM citrate produced specific activity
of 1.363±0.279, 2.246±0.870, and 4.186±0.200 nmol Pi/
mg/min (n=4), respectively. These values indicated that
when the citrate concentration was increased by 2-fold,
activities were also increased by about 2-fold in proportion
to citrate concentration (Fig. 5b). Furthermore, when the
concentration of citrate exceeds 20 mM, the activation
curve follows a sigmoidal response, consistent with previ-
ous findings (Cheng et al. 2007).
The structural changes of Δ148aa-hACC2 by citrate
were also evaluated using high-resolution AFM at nano-
scale resolution (Fig. 6). The purified Δ148aa-hACC2
without citrate showed almost homogeneous particle
distribution. However, citrate addition to Δ148aa-
hACC2 generated filamentous polymeric forms, signifi-
cantly larger than Δ148aa-hACC2 alone. These findings
not only support the formation of high molecular weight
polymers observed in Native-PAGE but also validate
that Δ148aa-hACC2 produced in silkworm possess full
functionality with proper allosteric modulations.
MW









Fig. 4 Dephosphorylation of purified Δ148aa-hACC2 influences cata-
lytic function. a Dephosphorylation of Δ148aa-hACC2 treated with
Lambda PP was assessed by Western blotting using a monoclonal anti-
phosphoserine antibody produced in mouse and an anti-mouse IgG-HRP.
b Lambda PP treated Δ148aa-hACC2 enhanced catalytic activity









Fig. 5 Polymerization and enzyme activities of Δ148aa-hACC2 were
modulated by citrate concentration. a Degree of polymerization of
Δ148aa-hACC2 by different concentration of citrate (0, 4, 8, 12, 16,
20, and 25mM). The polymerization was confirmed using Native-PAGE.
b Enzymatic activities by citrate concentration. All data are means ± S.D.
from three separate experiments
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Discussion
Acetyl-CoA carboxylase is a multidomain and multifunction-
al protein working as an energetic controller in homeostatic
lipid metabolism participating in fatty acid synthesis and fatty
acid oxidation (Tong 2013; Wakil and Abu-Elheiga 2009).
The catalytic function of ACC through a biotin prosthetic
group can be allosterically regulated by multiple factors in-
cluding posttranslational phosphorylation and dephosphory-
lation (Wakil and Abu-Elheiga 2009). In addition, tertiary
level regulation of ACC with small acidic proteins, i.e.,
Spot14 and Mig12, has been recently identified (Colbert
et al. 2010; Kim et al. 2010; Knobloch et al. 2013; Park
et al. 2013). Particularly, due to the pathophysiological rele-
vance of ACC2 in lipid metabolic syndrome associated with
obesity, diabetes, cancer, and cardiovascular disease, ACC2
activity regulation has been considered as a candidate target
for therapeutic interventions, which essentially requires au-
thentic bioengineered recombinant proteins (Abu-Elheiga
et al. 2001; Tong 2013; Tong and Harwood 2006). Here, we
successfully produced with high fidelity human ACC2 using
the silkworm BmNPV system armed with a proper posttrans-
lational modification machinery. The heterologous ACC2
harbors all necessary posttranslational biotinylation and phos-
phorylation, vital to maintain functional integrity. Thus, the
silkworm BmNPV bacmid system provides a reliable large-
scale production platform for eukaryotic proteins required for
posttranslational modifications.
Biotin is a water-soluble vitamin serving as a vital pros-
thetic group involved in five carboxylases in human
(Zempleni et al. 2009). In hACC2, biotin is covalently linked
to lysine 929 within a BCCP domain and forms carboxybiotin
using bicarbonate as the CO2 donor. Following a large con-
formational change, the carboxyl group from carboxybiotin is
transferred to acetyl-CoA to produce malonyl-CoA (Tong
2013).We revealed posttranslational biotinylation of function-
al recombinant hACC2 from silkworm, without any addition-
al supplement of biotin under silkworm rearing conditions.
We believe that this is the first demonstration of posttransla-
tional biotinylation in proteins expressed in silkworm B. mori.
ACC phosphorylation/dephosphorylation is one of the al-
losteric regulatory mechanisms. Phosphorylation of ACC by
AMP-activated protein kinase and cAMP-dependent protein
kinase inhibits the enzymatic activity of ACC, whereas de-
phosphorylation activates the catalytic function (Munday et al.
1988). Although several phosphorylation sites have been
identified, Ser212 (mouse sequence) phosphorylation was
recently recognized as an integral process in activity modula-
tion (Fullerton et al. 2013) where knock-in mice with substi-
tution of Ser212 with alanine displayed an increased ACC2
activity. Consistent with this, we demonstrated about a 2-fold
increased specific activity in dephosphorylated hACC2 com-
pared to the phosphorylated counterpart, underscoring that the
critical serine residue is fully accessible to phosphatase pro-
tein. ACC is also allosterically activated by citrate, which is a
metabolic intermediate produced in mitochondrial tricarbox-
ylic acid cycle. Although the concentrations of citrate required
to increase the enzymatic activity of ACC are much higher
than the physiological concentrations of citrate, citrate has
been widely used to modulate ACC function (Beaty and
Lane 1983a; Cheng et al. 2007; Thampy and Wakil 1988).
We demonstrated herein citrate-induced hACC2 catalytic
function enhancement and filamentous polymer formation.
In summary, a multifunctional human ACC2was successfully
produced using silkworm-based protein expression system.
Heterologous ACC2 was correctly folded with posttransla-
tional biotinylation and phosphorylation, retaining catalytic
activity and citrate-induced allosteric regulation. Moreover,
silkworm demonstrated a high yield of recombinant ACC2
production. Thus, the silkworm-based BmNPV expression
1 µm1 µm
(A) 148aa-hACC2 (B) 148aa-hACC2 + 15 mM citrate
Fig. 6 Atomic force microscopy nanoscale images ofΔ148aa-hACC2. a Δ148aa-hACC2 alone. b Δ148aa-hACC2 with 15 mM citrate after 20-min
incubation at 37 °C. Citrate induced the filaments formation
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method equipped with a proper posttranslational modification
machinery provides a large-scale eukaryotic protein produc-
tion platform for structural and functional research particularly
in the application of therapeutic drug discovery.
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